{
    "hands_on_practices": [
        {
            "introduction": "The ability to detect a pathogen using metagenomic sequencing is fundamentally a game of chance governed by sampling statistics. This exercise explores the stochastic nature of detection by modeling the sequencing process with basic probability, allowing you to calculate the likelihood of completely missing a low-abundance pathogen. By working through this problem , you will build a strong intuition for the trade-off between sequencing depth and the theoretical limit of detection, which defines the boundaries of what is possible with this technology.",
            "id": "5131994",
            "problem": "In metagenomic shotgun sequencing for pathogen discovery, assume that sequencing reads are independent and uniformly sampled from the pool of sequencing-accessible nucleic acid molecules. Let the true relative abundance of a target pathogen in the specimen be $f$, defined as the probability that any one read derives from the pathogen, and let the sequencing depth be $D$, defined as the total number of reads produced. Under these conditions, define the random variable $X$ to be the number of pathogen-derived reads observed.\n\nStarting from first principles of Bernoulli sampling and independence, derive the probability of observing zero pathogen-derived reads. Then, using the given values $f = 10^{-6}$ and $D = 10^{8}$, compute this probability. You may use an appropriate asymptotic approximation if justified by the parameters, but you must clearly articulate the reasoning. Round your final numerical probability to $3$ significant figures and express it as a decimal.\n\nFinally, briefly discuss the implications of your result for clinical reporting thresholds in metagenomic next-generation sequencing (NGS), for example when a laboratory requires at least $k$ reads for a positive report. Your discussion should be framed in terms of sampling variance and its contribution to false negatives under the stated assumptions, without invoking any unprovided shortcut formulas or empirical rules.",
            "solution": "The problem statement has been validated and is determined to be sound, well-posed, and scientifically grounded.\n\nThe problem asks for the derivation and calculation of the probability of observing zero pathogen-derived reads in a metagenomic shotgun sequencing experiment, and a discussion of the result's implications.\n\nThe core assumptions are that the sequencing reads are independent and uniformly sampled from the pool of nucleic acid molecules. This process can be modeled as a series of Bernoulli trials.\n\nLet $D$ be the total number of sequencing reads (the sequencing depth), which corresponds to the number of trials. Let $f$ be the true relative abundance of the pathogen, which is the probability that any single read originates from the pathogen. This corresponds to the probability of \"success\" in a single Bernoulli trial.\n\nThe random variable $X$ represents the total number of pathogen-derived reads observed in $D$ trials. Since the trials are independent and the probability of success $f$ is constant for each trial, $X$ follows a Binomial distribution, denoted as $X \\sim B(D, f)$.\n\nThe probability mass function (PMF) for a Binomial distribution gives the probability of observing exactly $k$ successes in $n$ trials:\n$$P(X=k) = \\binom{n}{k} p^k (1-p)^{n-k}$$\nIn our context, $n=D$, $p=f$, and we are interested in the case where $k=0$. Substituting these values into the PMF, we derive the probability of observing zero pathogen-derived reads:\n$$P(X=0) = \\binom{D}{0} f^0 (1-f)^{D-0}$$\nBy definition, $\\binom{D}{0} = 1$ and $f^0 = 1$. Therefore, the exact probability is:\n$$P(X=0) = (1-f)^D$$\n\nNow, we are asked to compute this probability for the given values $f = 10^{-6}$ and $D = 10^{8}$.\nThe direct calculation of $(1 - 10^{-6})^{10^{8}}$ is computationally cumbersome. The problem allows for an asymptotic approximation if justified. The conditions for the Poisson approximation to the Binomial distribution are that the number of trials $D$ is very large and the probability of success $f$ is very small. In our case, $D = 10^8$ is indeed very large, and $f = 10^{-6}$ is very small. Thus, the use of a Poisson approximation is well-justified.\n\nThe Binomial distribution $B(D, f)$ can be approximated by a Poisson distribution with parameter $\\lambda$, where $\\lambda$ is the expected number of successes.\n$$\\lambda = E[X] = Df$$\nLet's calculate $\\lambda$ for the given values:\n$$\\lambda = (10^8) \\times (10^{-6}) = 10^{2} = 100$$\nThe PMF of the Poisson distribution is:\n$$P(X=k) \\approx \\frac{\\lambda^k \\exp(-\\lambda)}{k!}$$\nWe want to find the probability of observing zero reads, i.e., $k=0$.\n$$P(X=0) \\approx \\frac{\\lambda^0 \\exp(-\\lambda)}{0!}$$\nSince $\\lambda^0 = 1$ and $0! = 1$, this simplifies to:\n$$P(X=0) \\approx \\exp(-\\lambda) = \\exp(-Df)$$\nThis approximation arises from the well-known limit definition of the exponential function:\n$$P(X=0) = (1-f)^D = \\left(1 - \\frac{Df}{D}\\right)^D = \\left(1 - \\frac{\\lambda}{D}\\right)^D$$\nFor large $D$, this expression converges to $\\exp(-\\lambda)$.\n\nNow, we compute the numerical value:\n$$P(X=0) \\approx \\exp(-100)$$\nCalculating this value and rounding to $3$ significant figures:\n$$\\exp(-100) \\approx 3.7200759... \\times 10^{-44}$$\nRounded to $3$ significant figures, the probability is $3.72 \\times 10^{-44}$.\n\nFinally, for the discussion on implications, the result $P(X=0) \\approx 3.72 \\times 10^{-44}$ is the probability of a false negative (failing to detect the pathogen at all) when the pathogen is present at a relative abundance of $f = 10^{-6}$ and the sequencing depth is $D = 10^8$. The expected number of pathogen reads is $\\lambda = Df = 100$.\n\nThe fact that $P(X=0)$ is non-zero, even if infinitesimally small in this case, illustrates a fundamental principle: the stochastic nature of sequencing introduces sampling variance. Even when a pathogen is present and the expected number of reads is high ($100$), there is a finite probability of observing zero reads by chance.\n\nIf a clinical laboratory sets a reporting threshold of requiring at least $k$ reads for a positive report (e.g., $k=3$), a false negative occurs if the observed number of reads $X$ is less than $k$. The probability of this event, $P(X < k)$, is the sum of probabilities $P(X=0), P(X=1), \\dots, P(X=k-1)$. The value $P(X=0)$ we calculated represents the absolute minimum false-negative rate for any threshold $k \\ge 1$.\n\nWhile the false-negative rate is exceedingly low for the given parameters, this scenario changes dramatically if the product $\\lambda=Df$ is small. For example, if a lower sequencing depth were used (e.g., $D=10^6$) for the same pathogen abundance ($f=10^{-6}$), the expected number of reads would be $\\lambda = 1$. The probability of observing zero reads would then be $P(X=0) \\approx \\exp(-1) \\approx 0.368$. In this situation, there would be a $36.8\\%$ chance of missing the pathogen entirely, a clinically unacceptable false-negative rate.\n\nThis demonstrates that sampling variance is a critical contributor to false negatives in metagenomic diagnostics. The ability to reliably detect a pathogen is not guaranteed simply by its presence; it is governed by the probability distribution of observed reads, which in turn depends fundamentally on the interplay between pathogen abundance ($f$) and sequencing depth ($D$). Setting a reporting threshold $k$ must be balanced against the risk of false negatives, a risk that is mathematically determined by the parameter $\\lambda=Df$.",
            "answer": "$$\n\\boxed{3.72 \\times 10^{-44}}\n$$"
        },
        {
            "introduction": "Once a pathogen's presence is confirmed, the critical next step is often to determine its concentration, a key factor in clinical decision-making. This practice  guides you through the process of converting relative read counts into an absolute quantity, such as copies per milliliter, using an internal spike-in control. Deriving the quantification formula from first principles will illuminate the crucial assumptions about laboratory processes and bioinformatics that must hold for the result to be accurate.",
            "id": "5132005",
            "problem": "A cerebrospinal fluid specimen is analyzed by metagenomic shotgun sequencing for pathogen discovery. A synthetic double-stranded DNA spike-in control is added immediately prior to lysis to enable absolute quantification. You may assume the following foundations: during shotgun library preparation and sequencing, fragments are sampled without replacement from the pool of input nucleic acid molecules; under uniform and unbiased sampling, the expected number of sequencing reads assigned to any source is proportional to the total number of input nucleotides contributed by that source; and, for a haploid organism, the total nucleotides contributed by that source equal the number of genome copies times the haploid genome length. Internally controlled absolute quantification uses the spike-in to calibrate unknowns.\n\nThe experiment yields the following measured and known quantities:\n- Input sample volume processed: $V_{\\text{in}} = 1.00 \\ \\mathrm{mL}$.\n- Spike-in molecules added at lysis: $N_{\\text{spike}} = 5.00 \\times 10^{7}$ genome copies of a linearized plasmid of length $L_{\\text{spike}} = 3.000 \\times 10^{3} \\ \\mathrm{bp}$.\n- Sequencing configuration: paired-end reads of equal length across the run; duplicate and low-quality reads are removed prior to taxonomic assignment.\n- Post-processing read counts assigned by competitive mapping:\n  - Human: $2.70 \\times 10^{7}$ read pairs.\n  - Spike-in: $6.00 \\times 10^{4}$ read pairs.\n  - A single bacterial pathogen of interest (haploid): $4.00 \\times 10^{2}$ read pairs.\n  - All other taxa combined: negligible for this calculation.\n- The haploid genome length of the detected bacterial pathogen is $L_{\\text{path}} = 2.000 \\times 10^{6} \\ \\mathrm{bp}$.\n\nUsing first principles and only the foundations stated above, derive from scratch an expression to estimate the bacterial pathogen genome copies per milliliter in the original sample and compute its value. You must explicitly justify each modeling step you introduce in the derivation. Round your final numerical answer to three significant figures. Express the final concentration in copies $\\mathrm{mL}^{-1}$.\n\nIn addition to the computation, briefly identify the core assumptions required for the internal standard calibration to be valid in this context and explain, at a conceptual level, why they are necessary. Do not use any pre-memorized shortcut formulas; instead, build your reasoning from the stated foundations and definitions only. Your final reported answer must be a single real number.",
            "solution": "The problem statement has been critically validated and is deemed to be self-contained, scientifically grounded, and well-posed. All necessary data and foundational principles for a unique and meaningful solution are provided. We may therefore proceed with the derivation and computation.\n\nThe central foundation provided for this analysis is that the expected number of sequencing reads assigned to any source is proportional to the total number of input nucleotides from that source. Let $C_i$ represent the number of sequencing read pairs assigned to source $i$, and let $T_i$ be the total number of nucleotides contributed by source $i$ to the initial nucleic acid pool prior to sequencing. The proportionality can be expressed as:\n$$E[C_i] = k \\cdot T_i$$\nwhere $E[C_i]$ is the expected value of the read count for source $i$, and $k$ is a constant of proportionality that depends on the total sequencing depth and other systemic factors, but is assumed to be identical for all sources of DNA in the sample.\n\nThis principle is applied to the two non-host sources of interest: the bacterial pathogen (denoted 'path') and the internal spike-in control (denoted 'spike').\nFor the pathogen:\n$$E[C_{\\text{path}}] = k \\cdot T_{\\text{path}}$$\nFor the spike-in:\n$$E[C_{\\text{spike}}] = k \\cdot T_{\\text{spike}}$$\nBy taking the ratio of these two equations, the unknown constant of proportionality $k$ is eliminated. This is the fundamental basis of internal calibration, as it normalizes the measurement of the unknown analyte (pathogen) against a known internal reference (spike-in).\n$$\\frac{E[C_{\\text{path}}]}{E[C_{\\text{spike}}]} = \\frac{k \\cdot T_{\\text{path}}}{k \\cdot T_{\\text{spike}}} = \\frac{T_{\\text{path}}}{T_{\\text{spike}}}$$\nIn a real experiment, we use the observed read counts as estimates for their expected values, $C_i \\approx E[C_i]$. This approximation is reasonable for sufficiently large read counts.\n$$\\frac{C_{\\text{path}}}{C_{\\text{spike}}} = \\frac{T_{\\text{path}}}{T_{\\text{spike}}}$$\nThe second foundational principle states that for a haploid organism, the total number of nucleotides is the product of the number of genome copies and the haploid genome length. Let $N_i$ be the number of genome copies and $L_i$ be the genome length in base pairs (bp) for source $i$.\nThe total nucleotides for the pathogen are:\n$$T_{\\text{path}} = N_{\\text{path}} \\cdot L_{\\text{path}}$$\nThe total nucleotides for the spike-in are:\n$$T_{\\text{spike}} = N_{\\text{spike}} \\cdot L_{\\text{spike}}$$\nHere, $N_{\\text{path}}$ represents the total number of pathogen genome copies present in the initial sample volume, $V_{\\text{in}}$.\n\nSubstituting these expressions back into the ratio equation yields:\n$$\\frac{C_{\\text{path}}}{C_{\\text{spike}}} = \\frac{N_{\\text{path}} \\cdot L_{\\text{path}}}{N_{\\text{spike}} \\cdot L_{\\text{spike}}}$$\nOur objective is to determine the concentration of the pathogen, which first requires solving for the absolute number of pathogen genome copies, $N_{\\text{path}}$. Rearranging the equation:\n$$N_{\\text{path}} = N_{\\text{spike}} \\cdot \\frac{C_{\\text{path}}}{C_{\\text{spike}}} \\cdot \\frac{L_{\\text{spike}}}{L_{\\text{path}}}$$\nThis derived expression allows us to calculate the number of pathogen genomes in the processed sample volume by relating the ratio of observed read counts to the ratio of known genome lengths, scaled by the known quantity of the spike-in control.\n\nThe problem requires the final answer as a concentration in copies per milliliter. Let this concentration be $\\rho_{\\text{path}}$. It is defined as the total number of pathogen copies, $N_{\\text{path}}$, divided by the input sample volume, $V_{\\text{in}}$.\n$$\\rho_{\\text{path}} = \\frac{N_{\\text{path}}}{V_{\\text{in}}}$$\nSubstituting the expression for $N_{\\text{path}}$:\n$$\\rho_{\\text{path}} = \\frac{1}{V_{\\text{in}}} \\left( N_{\\text{spike}} \\cdot \\frac{C_{\\text{path}}}{C_{\\text{spike}}} \\cdot \\frac{L_{\\text{spike}}}{L_{\\text{path}}} \\right)$$\nNow we substitute the given numerical values into this expression.\nGiven:\n- Input volume: $V_{\\text{in}} = 1.00 \\ \\mathrm{mL}$\n- Spike-in copies: $N_{\\text{spike}} = 5.00 \\times 10^{7}$ copies\n- Spike-in read pairs: $C_{\\text{spike}} = 6.00 \\times 10^{4}$\n- Pathogen read pairs: $C_{\\text{path}} = 4.00 \\times 10^{2}$\n- Spike-in length: $L_{\\text{spike}} = 3.000 \\times 10^{3} \\ \\mathrm{bp}$\n- Pathogen length: $L_{\\text{path}} = 2.000 \\times 10^{6} \\ \\mathrm{bp}$\n\nCalculation:\n$$\\rho_{\\text{path}} = \\frac{1}{1.00 \\ \\mathrm{mL}} \\left( (5.00 \\times 10^{7}) \\cdot \\frac{4.00 \\times 10^{2}}{6.00 \\times 10^{4}} \\cdot \\frac{3.000 \\times 10^{3}}{2.000 \\times 10^{6}} \\right)$$\n$$\\rho_{\\text{path}} = \\left( 5.00 \\times 10^{7} \\right) \\cdot \\left( \\frac{4.00}{6.00} \\times 10^{2-4} \\right) \\cdot \\left( \\frac{3.000}{2.000} \\times 10^{3-6} \\right) \\ \\mathrm{copies} \\cdot \\mathrm{mL}^{-1}$$\n$$\\rho_{\\text{path}} = \\left( 5.00 \\times \\frac{2}{3} \\times 1.5 \\right) \\cdot \\left( 10^{7} \\times 10^{-2} \\times 10^{-3} \\right) \\ \\mathrm{copies} \\cdot \\mathrm{mL}^{-1}$$\n$$\\rho_{\\text{path}} = \\left( 5.00 \\times \\frac{2}{3} \\times \\frac{3}{2} \\right) \\cdot 10^{7-2-3} \\ \\mathrm{copies} \\cdot \\mathrm{mL}^{-1}$$\n$$\\rho_{\\text{path}} = 5.00 \\cdot 10^{2} \\ \\mathrm{copies} \\cdot \\mathrm{mL}^{-1}$$\n$$\\rho_{\\text{path}} = 500 \\ \\mathrm{copies} \\cdot \\mathrm{mL}^{-1}$$\nRounding to three significant figures as requested, the value is $5.00 \\times 10^2$.\n\nIn addition to the computation, we identify the core assumptions required for this internal standard calibration to be valid.\n\n1.  **Equivalent Processing Efficiency from Lysis Onward**: The spike-in control, a synthetic naked DNA molecule, is added prior to sample lysis. The fundamental assumption is that the pathogen's genomic DNA, once released from the cell, and the spike-in DNA behave identically throughout all subsequent workflow steps. This includes DNA extraction/purification, fragmentation, library construction (end-repair, A-tailing, adapter ligation), and PCR amplification. Crucially, this requires that the lysis step itself is non-biasing and effectively releases the nucleic acid from the pathogen. If the pathogen has a robust cell wall that is resistant to the lysis method, its DNA will be under-represented in the initial pool, leading to a significant underestimation of its concentration. The calibration model implicitly assumes $100\\%$ lysis efficiency or that the efficiency is identical for all organisms, which is a strong assumption.\n\n2.  **Unbiased Sequencing and Mapping**: The model is based on \"uniform and unbiased sampling\". This assumes that DNA fragments from the pathogen and the spike-in have an equal probability of being sequenced, regardless of their primary sequence. Factors such as extreme GC content ($((G+C)/(A+T+G+C))$) can introduce known biases during PCR amplification and sequencing. Furthermore, the bioinformatics analysis must be unbiased. The algorithm used for competitive mapping must assign reads to their correct origin with equal accuracy and precision for both pathogen and spike-in sequences. If pathogen sequences are more likely to be discarded as ambiguous or mis-mapped (e.g., due to homology with the human genome), the count $C_{\\text{path}}$ will be artificially low, again leading to an underestimate of the pathogen load.\n\n3.  **Accurate Knowledge of Genome Lengths**: The calculation explicitly depends on the genome lengths $L_{\\text{path}}$ and $L_{\\text{spike}}$. The method assumes that the values used are accurate. While the spike-in length is precisely known by design, the pathogen genome length is an estimate based on a reference. Significant variation in genome size between the detected strain and the reference genome could introduce a systematic error in the quantification. The assumption is that the reference genome length is a sufficiently accurate representation of the actual genome length of the pathogen in the sample.",
            "answer": "$$\n\\boxed{5.00 \\times 10^{2}}\n$$"
        },
        {
            "introduction": "A 'positive' or 'negative' result from a highly sensitive assay is not as straightforward as it seems; its true meaning depends heavily on the clinical context. This final practice  delves into the relationship between a test's intrinsic performance metrics, such as sensitivity ($s$) and specificity ($c$), and its real-world predictive power. By applying Bayes' theorem, you will derive the Positive and Negative Predictive Values and analyze how profoundly disease prevalence ($\\pi$) can alter the interpretation of a diagnostic result.",
            "id": "5131949",
            "problem": "A clinical laboratory deploys metagenomic shotgun sequencing (mNGS) for pathogen discovery in cerebrospinal fluid samples. In this context, a binary decision rule calls a specimen \"positive\" when pathogen-associated reads exceed a rigorously validated threshold, and \"negative\" otherwise. Let sensitivity $s$ be defined as $P(\\text{positive} \\mid \\text{pathogen truly present})$, specificity $c$ be defined as $P(\\text{negative} \\mid \\text{pathogen truly absent})$, and prevalence $\\pi$ be defined as $P(\\text{pathogen truly present})$ in the tested population. Positive Predictive Value (PPV) and Negative Predictive Value (NPV) are respectively defined as $P(\\text{pathogen truly present} \\mid \\text{positive})$ and $P(\\text{pathogen truly absent} \\mid \\text{negative})$.\n\nStarting only from the fundamental definitions of sensitivity, specificity, and prevalence, together with Bayes' theorem, perform the following:\n\n1. Derive general closed-form expressions for PPV and NPV as functions of $s$, $c$, and $\\pi$ for this assay, without introducing any additional assumptions beyond the stated definitions and the law of total probability.\n\n2. Focusing on the low-prevalence regime relevant to broad mNGS screening, perform a first-order asymptotic analysis of PPV and NPV around $\\pi = 0$. Specifically, determine the coefficients $\\alpha$ and $\\beta$ such that\n$$\n\\text{PPV}(\\pi) = \\alpha\\,\\pi + \\mathcal{O}\\!\\left(\\pi^{2}\\right)\\quad \\text{and}\\quad \\text{NPV}(\\pi) = 1 - \\beta\\,\\pi + \\mathcal{O}\\!\\left(\\pi^{2}\\right)\n$$\nas $\\pi \\to 0$, expressed in terms of $s$ and $c$. Assume $0 < s < 1$ and $0 < c < 1$ so that false positives and false negatives are both possible in practice due to contamination and stochastic sampling.\n\nReport the final result as the pair $\\left(\\alpha,\\beta\\right)$ in a single row matrix. No numerical rounding is required, and no units apply. Express all probabilities as decimals or fractions, not as percentages.",
            "solution": "The problem requires the derivation of expressions for Positive Predictive Value ($\\text{PPV}$) and Negative Predictive Value ($\\text{NPV}$) and their subsequent first-order asymptotic analysis in a low-prevalence regime. The problem is well-posed and scientifically grounded in the principles of probability theory and diagnostic test evaluation.\n\nLet us define the events as follows:\n- $D^{+}$: The event that a pathogen is truly present.\n- $D^{-}$: The event that a pathogen is truly absent.\n- $T^{+}$: The event that the test result is positive.\n- $T^{-}$: The event that the test result is negative.\n\nThe definitions provided in the problem statement can be translated into conditional probabilities:\n- Prevalence: $\\pi = P(D^{+})$. Consequently, $P(D^{-}) = 1 - P(D^{+}) = 1 - \\pi$.\n- Sensitivity: $s = P(T^{+} \\mid D^{+})$. This implies the false negative rate is $P(T^{-} \\mid D^{+}) = 1 - s$.\n- Specificity: $c = P(T^{-} \\mid D^{-})$. This implies the false positive rate is $P(T^{+} \\mid D^{-}) = 1 - c$.\n\nThe values to be derived are:\n- Positive Predictive Value: $\\text{PPV} = P(D^{+} \\mid T^{+})$.\n- Negative Predictive Value: $\\text{NPV} = P(D^{-} \\mid T^{-})$.\n\n**1. Derivation of PPV and NPV**\n\nWe will use Bayes' theorem, which states that for events $A$ and $B$, $P(A \\mid B) = \\frac{P(B \\mid A) P(A)}{P(B)}$. The denominator $P(B)$ is often expanded using the law of total probability.\n\n**Derivation of PPV:**\nApplying Bayes' theorem to the definition of $\\text{PPV}$:\n$$\n\\text{PPV} = P(D^{+} \\mid T^{+}) = \\frac{P(T^{+} \\mid D^{+}) P(D^{+})}{P(T^{+})}\n$$\nThe marginal probability of a positive test, $P(T^{+})$, is found by conditioning on the true pathogen status using the law of total probability:\n$$\nP(T^{+}) = P(T^{+} \\mid D^{+}) P(D^{+}) + P(T^{+} \\mid D^{-}) P(D^{-})\n$$\nSubstituting the given definitions:\n$$\nP(T^{+}) = s \\pi + (1 - c)(1 - \\pi)\n$$\nSubstituting this expression for $P(T^{+})$ into the equation for $\\text{PPV}$:\n$$\n\\text{PPV}(\\pi) = \\frac{s \\pi}{s \\pi + (1 - c)(1 - \\pi)}\n$$\nThis is the general closed-form expression for $\\text{PPV}$ as a function of $s$, $c$, and $\\pi$.\n\n**Derivation of NPV:**\nSimilarly, applying Bayes' theorem to the definition of $\\text{NPV}$:\n$$\n\\text{NPV} = P(D^{-} \\mid T^{-}) = \\frac{P(T^{-} \\mid D^{-}) P(D^{-})}{P(T^{-})}\n$$\nThe marginal probability of a negative test, $P(T^{-})$, is found using the law of total probability:\n$$\nP(T^{-}) = P(T^{-} \\mid D^{-}) P(D^{-}) + P(T^{-} \\mid D^{+}) P(D^{+})\n$$\nSubstituting the given definitions:\n$$\nP(T^{-}) = c (1 - \\pi) + (1 - s) \\pi\n$$\nSubstituting this expression for $P(T^{-})$ into the equation for $\\text{NPV}$:\n$$\n\\text{NPV}(\\pi) = \\frac{c (1 - \\pi)}{c (1 - \\pi) + (1 - s) \\pi}\n$$\nThis is the general closed-form expression for $\\text{NPV}$ as a function of $s$, $c$, and $\\pi$.\n\n**2. Asymptotic Analysis for $\\pi \\to 0$**\n\nWe are asked to find the coefficients $\\alpha$ and $\\beta$ in the first-order Taylor series expansions of $\\text{PPV}(\\pi)$ and $\\text{NPV}(\\pi)$ around $\\pi = 0$.\nA first-order Taylor expansion of a function $f(\\pi)$ around $\\pi=0$ is given by $f(\\pi) = f(0) + f'(0)\\pi + \\mathcal{O}(\\pi^2)$.\n\n**Analysis of PPV($\\pi$):**\nThe function is $\\text{PPV}(\\pi) = \\frac{s \\pi}{s \\pi + (1 - c)(1 - \\pi)}$.\nFirst, we evaluate $\\text{PPV}(0)$:\n$$\n\\text{PPV}(0) = \\frac{s(0)}{s(0) + (1 - c)(1 - 0)} = \\frac{0}{1 - c} = 0\n$$\nThe assumption $0 < c < 1$ ensures the denominator is non-zero.\nNext, we find the derivative $\\frac{d}{d\\pi} \\text{PPV}(\\pi)$. Let's rewrite the expression to simplify differentiation:\n$$\n\\text{PPV}(\\pi) = \\frac{s \\pi}{(1 - c) + (s + c - 1)\\pi}\n$$\nUsing the quotient rule for differentiation, $\\left(\\frac{u}{v}\\right)' = \\frac{u'v - uv'}{v^2}$, with $u(\\pi) = s\\pi$ and $v(\\pi) = (1 - c) + (s + c - 1)\\pi$:\n$u'(\\pi) = s$\n$v'(\\pi) = s + c - 1$\n$$\n\\frac{d}{d\\pi} \\text{PPV}(\\pi) = \\frac{s[(1 - c) + (s + c - 1)\\pi] - s\\pi[s + c - 1]}{[(1 - c) + (s + c - 1)\\pi]^2}\n$$\n$$\n\\frac{d}{d\\pi} \\text{PPV}(\\pi) = \\frac{s(1 - c) + s(s + c - 1)\\pi - s(s + c - 1)\\pi}{[(1 - c) + (s + c - 1)\\pi]^2} = \\frac{s(1 - c)}{[(1 - c) + (s + c - 1)\\pi]^2}\n$$\nEvaluating the derivative at $\\pi = 0$:\n$$\n\\text{PPV}'(0) = \\frac{s(1 - c)}{[(1 - c) + 0]^2} = \\frac{s(1 - c)}{(1 - c)^2} = \\frac{s}{1 - c}\n$$\nThe expansion is $\\text{PPV}(\\pi) = \\text{PPV}(0) + \\text{PPV}'(0)\\pi + \\mathcal{O}(\\pi^2) = 0 + \\frac{s}{1 - c}\\pi + \\mathcal{O}(\\pi^2)$.\nComparing this to the specified form $\\text{PPV}(\\pi) = \\alpha\\,\\pi + \\mathcal{O}(\\pi^2)$, we identify the coefficient $\\alpha$:\n$$\n\\alpha = \\frac{s}{1 - c}\n$$\n\n**Analysis of NPV($\\pi$):**\nThe function is $\\text{NPV}(\\pi) = \\frac{c(1 - \\pi)}{c(1 - \\pi) + (1 - s)\\pi}$.\nFirst, we evaluate $\\text{NPV}(0)$:\n$$\n\\text{NPV}(0) = \\frac{c(1 - 0)}{c(1 - 0) + (1 - s)(0)} = \\frac{c}{c} = 1\n$$\nThe assumption $0 < c < 1$ ensures the denominator is non-zero.\nNext, we find the derivative $\\frac{d}{d\\pi} \\text{NPV}(\\pi)$. Let's rewrite the expression:\n$$\n\\text{NPV}(\\pi) = \\frac{c - c\\pi}{c + (1 - s - c)\\pi}\n$$\nUsing the quotient rule with $u(\\pi) = c - c\\pi$ and $v(\\pi) = c + (1 - s - c)\\pi$:\n$u'(\\pi) = -c$\n$v'(\\pi) = 1 - s - c$\n$$\n\\frac{d}{d\\pi} \\text{NPV}(\\pi) = \\frac{(-c)[c + (1 - s - c)\\pi] - (c - c\\pi)[1 - s - c]}{[c + (1 - s - c)\\pi]^2}\n$$\n$$\n\\frac{d}{d\\pi} \\text{NPV}(\\pi) = \\frac{-c^2 - c(1 - s - c)\\pi - c(1 - s - c) + c(1 - s - c)\\pi}{[c + (1 - s - c)\\pi]^2} = \\frac{-c^2 - c(1 - s - c)}{[c + (1 - s - c)\\pi]^2}\n$$\n$$\n\\frac{d}{d\\pi} \\text{NPV}(\\pi) = \\frac{-c[c + (1 - s - c)]}{[c + (1 - s - c)\\pi]^2} = \\frac{-c(1 - s)}{[c + (1 - s - c)\\pi]^2}\n$$\nEvaluating the derivative at $\\pi = 0$:\n$$\n\\text{NPV}'(0) = \\frac{-c(1 - s)}{[c + 0]^2} = \\frac{-c(1 - s)}{c^2} = -\\frac{1 - s}{c}\n$$\nThe expansion is $\\text{NPV}(\\pi) = \\text{NPV}(0) + \\text{NPV}'(0)\\pi + \\mathcal{O}(\\pi^2) = 1 - \\frac{1 - s}{c}\\pi + \\mathcal{O}(\\pi^2)$.\nComparing this to the specified form $\\text{NPV}(\\pi) = 1 - \\beta\\,\\pi + \\mathcal{O}(\\pi^2)$, we identify the coefficient $\\beta$:\n$$\n\\beta = \\frac{1 - s}{c}\n$$\n\nThe resulting coefficients are $\\alpha = \\frac{s}{1 - c}$ and $\\beta = \\frac{1 - s}{c}$. The coefficient $\\alpha$ is the likelihood ratio of a positive test ($LR+$), and $\\beta$ is the likelihood ratio of a negative test ($LR-$).\n\nThe required pair $(\\alpha, \\beta)$ is therefore $\\left(\\frac{s}{1 - c}, \\frac{1 - s}{c}\\right)$.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n\\frac{s}{1 - c} & \\frac{1 - s}{c}\n\\end{pmatrix}\n}\n$$"
        }
    ]
}